Notice2022-19559
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 12, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 175 (Monday, September 12, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 175 (Monday, September 12, 2022)]
[Notices]
[Pages 55810-55812]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1011]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Emergency Epidemic Investigations'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on April 18, 2022 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to
[[Page 55811]]
allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Emergency Epidemic Investigation (OMB Control No. 0920-1011, Exp.
1/31/2023)--Extension--Center for Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC previously conducted Emergency Epidemic Investigations (EEIs)
under Office of Management and Budget (OMB) Control No. 0920-0008. In
2013, CDC received OMB approval (OMB Control No. 0920-1011) for a new
OMB generic clearance to collect vital information during EEIs in
response to outbreaks or other urgent public health events (i.e.,
natural, biological, chemical, nuclear, radiological) characterized by
undetermined agents, undetermined sources, undetermined transmission,
or undetermined risk factors. This Generic clearance was most recently
approved for a three-year Extension, which expires on 1/31/2023. CDC
seeks OMB approval for an Extension of this Generic clearance for an
additional three-year period.
Supporting effective EEIs is one of the most important ways that
CDC protects the health of the public. CDC is frequently called upon to
conduct EEIs at the request of local, state, or international health
authorities seeking support to respond to outbreaks or urgent public
health events. In response to external partner requests, CDC provides
necessary epidemiologic support to identify the agents, sources, modes
of transmission, or risk factors to effectively implement rapid
prevention and control measures to protect the public's health. Data
collection is a critical component of the epidemiologic support
provided by CDC; data are analyzed to determine the agents, sources,
modes of transmission, or risk factors so that effective prevention and
control measures can be implemented. During an unanticipated outbreak
or urgent public health event, immediate action by CDC is necessary to
minimize or prevent public harm.
The legal justification for EEIs are found in the Public Health
Service Act (42 U.S.C. Sec. 301 [241] (a). Successful investigations
are dependent on rapid and flexible data collection that evolves during
the investigation and is customized to the unique circumstances of each
outbreak or urgent public health event. Data collection elements will
be those necessary to identify the agents, sources, mode of
transmission, or risk factors. Examples of potential data collection
methods include telephone or face-to-face interview; email, web, or
other type of electronic questionnaire; paper-and-pencil questionnaire;
focus groups; medical record review and abstraction; laboratory record
review and abstraction; collection of clinical samples; and
environmental assessment. Respondents will vary depending on the nature
of the outbreak or urgent public health event; examples of potential
respondents include health care professionals, patients, laboratorians,
and the general public. Participation in EEIs is voluntary and there
are no anticipated costs to respondents other than their time. CDC will
use the information gathered during EEIs to rapidly identify and
effectively implement measures to minimize or prevent public harm.
CDC projects 60 EEIs in response to outbreaks or urgent public
health events characterized by undetermined agents, undetermined
sources, undetermined transmission, or undetermined risk factors
annually. The projected average number of respondents is 200 per EEI,
for a total of 12,000 respondents. CDC estimates the average burden per
response is 0.5 hours per respondent, and each respondent will be asked
to respond once. CDC requests OMB approval for a total of 6,000
estimated annual burden hours. OMB approval is requested for three
years, and there is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Emergency Epidemic Investigation Emergency Epidemic 12,000 1 30/60
Participants. Investigation Data
Collection Instruments.
----------------------------------------------------------------------------------------------------------------
[[Page 55812]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-19559 Filed 9-9-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on September 12, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.